MorphoSys

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.

Company Growth (employees)
Type
Public
HQ
Planegg, DE
Founded
1992
Size (employees)
343 (est)-2%
MorphoSys was founded in 1992 and is headquartered in Planegg, DE

Key People/Management at MorphoSys

Simon E. Moroney

Simon E. Moroney

Chief Executive Officer
Jens Holstein

Jens Holstein

Chief Financial Officer
Karin Eastham

Karin Eastham

Member & Supervisory Board
Walter Blattler

Walter Blattler

Member & Supervisory Board
Marc Cluzel

Marc Cluzel

Member & Supervisory Board
Daniel Camus

Daniel Camus

Member & Supervisory Board

MorphoSys Office Locations

MorphoSys has an office in Planegg
Planegg, DE (HQ)
48 Lena-Christ-Straße

MorphoSys Financials and Metrics

MorphoSys Financials

EUR

Market capitalization (04-Oct-2017)

2.1 b

Closing share price (04-Oct-2017)

72.8
MorphoSys's current market capitalization is €2.1 b.
Show all financial metrics

MorphoSys Market Value History

MorphoSys's Web-traffic and Trends

MorphoSys Online and Social Media Presence

MorphoSys News and Updates

Antibody Library Technologies Market Estimated to Exhibit at 4.4% CAGR during 2016-2026

Demand for antibody library technologies is expected to surge, as the arrival of advanced antibodies and their display technologies continue to reduce complexities of life science and biotechnology research. Posted via Industry Today. Follow us on Twitter @IndustryToday

MorphoSys Company Life and Culture

You may also be interested in